During the 10th European Craniofacial Congress in 2015, the European Cleft Palate Craniofacial Association (ECPCA) was founded. The ECPCA promotes and supports the management of cleft lip and palate deformities, and related craniofacial anomalies in Europe by organizing a multi-disciplinary European congress once every four years for dissemination of experience and knowledge in this field.
The 2019 congress will take place in Utrecht, the Netherlands on 12 – 15 June 2019 and will bring together experts, practitioners and companies involved in the treatment of cleft lip palate/craniofacial malformations. Professionals attending this congress will benefit from high-level scientific presentations, knowledge sharing and networking opportunities, with the overall goal of promoting understanding and treatment of these diseases.
Theme of the 2019 congress is Future perspectives in research & therapy. With this theme we would like to explore possibilities such as robotic involvement in surgery, 3-D printing and future applications of regenerative medicine, but also include new developments in modalities eg. genetics in diagnosing craniofacial anomalies.
The ECPCA aims to be a forum for all cleft palate and craniofacial teams in Europe. It is our purpose to bring together the best of European science in the field during this meeting, completed with invited speakers from around the globe.
Over a 3 day meeting, the highlights will be:
This initiative creates the perfect opportunity to join forces with a variety of stakeholders to co-create a new congress that is truly different from all others; and we would like you to be part of it from the beginning!
We look forward to welcoming you, and please feel free to contact us for any questions, suggestions or concerns!
More information: https://ecpca.eu/
RT @imvanlangen: Steeds meer mensen met G6PD-deficiëntie (erfelijke aandoening die met name voorkomt bij migranten uit Midden-Oosten en Afr…
RT @margreetausems: Uit wetenschappelijk onderzoek blijkt dat bij Turkse en Marokkaanse vrouwen met borstkanker bij wie wél een dna-test wo…